Wave Life Sciences (WVE) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $241.4 million.
- Wave Life Sciences' Liabilities and Shareholders Equity fell 3267.08% to $241.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 526.59%. This contributed to the annual value of $352.2 million for FY2024, which is 2809.9% up from last year.
- Wave Life Sciences' Liabilities and Shareholders Equity amounted to $241.4 million in Q3 2025, which was down 3267.08% from $252.4 million recorded in Q2 2025.
- Over the past 5 years, Wave Life Sciences' Liabilities and Shareholders Equity peaked at $358.5 million during Q3 2024, and registered a low of $146.4 million during Q4 2022.
- Over the past 5 years, Wave Life Sciences' median Liabilities and Shareholders Equity value was $230.0 million (recorded in 2023), while the average stood at $235.5 million.
- Per our database at Business Quant, Wave Life Sciences' Liabilities and Shareholders Equity tumbled by 3533.14% in 2021 and then soared by 8782.47% in 2023.
- Over the past 5 years, Wave Life Sciences' Liabilities and Shareholders Equity (Quarter) stood at $207.0 million in 2021, then dropped by 29.28% to $146.4 million in 2022, then surged by 87.82% to $274.9 million in 2023, then grew by 28.1% to $352.2 million in 2024, then plummeted by 31.47% to $241.4 million in 2025.
- Its Liabilities and Shareholders Equity stands at $241.4 million for Q3 2025, versus $252.4 million for Q2 2025 and $288.3 million for Q1 2025.